Cargando…

Sulforaphane‐induced metabolomic responses with epigenetic changes in estrogen receptor positive breast cancer cells

Estrogen is a risk factor for breast cancer. The isothiocyanate sulforaphane (SFN), found in cruciferous vegetables, has been identified as an effective chemopreventive agent, and may prevent or treat breast cancer by reversing estrogen‐induced metabolic changes. Here, we investigated metabolic chan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Shuyuan, Wang, Li, Zhang, Zhan, Chen, Feng, Wu, Qian, Li, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275259/ https://www.ncbi.nlm.nih.gov/pubmed/30524952 http://dx.doi.org/10.1002/2211-5463.12543

Ejemplares similares

Effects of sulforaphane on breast cancer based on metabolome and microbiome
por: Cao, Shuyuan, et al.
Publicado: (2023)

The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation
por: Paul, Bidisha, et al.
Publicado: (2018)

Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia
por: Wang, Ruoyu, et al.
Publicado: (2022)

Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
por: Zhou, Xianxiao, et al.
Publicado: (2013)

A recent overview on sulforaphane as a dietary epigenetic modulator
por: Hyun, Tae Kyung
Publicado: (2020)

Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
por: Ao, Ada, et al.
Publicado: (2011)

Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
por: Meeran, Syed M., et al.
Publicado: (2010)

AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner
por: Jian, Lei, et al.
Publicado: (2020)

Identification of Estrogen Response Element in Aquaporin-3 Gene that Mediates Estrogen-induced Cell Migration and Invasion in Estrogen Receptor-positive Breast Cancer
por: Huang, Yi-Ting, et al.
Publicado: (2015)

Effects of caffeic acid on epigenetics in the brain of rats with chronic unpredictable mild stress
por: Hu, Jinye, et al.
Publicado: (2020)

Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
por: Zhao, Shen, et al.
Publicado: (2019)

ESR1 alterations and metastasis in estrogen receptor positive breast cancer
por: Lei, Jonathan T., et al.
Publicado: (2019)

Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway
por: Su, Xuling, et al.
Publicado: (2018)

Role of Estrogen Receptor-Positive/Negative Ratios in Regulating Breast Cancer
por: Li, Yanchu, et al.
Publicado: (2022)

Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer
por: Fuentes-Mattei, Enrique, et al.
Publicado: (2014)

Mouse models of estrogen receptor-positive breast cancer
por: Mohibi, Shakur, et al.
Publicado: (2011)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
por: Porras, Lucas, et al.
Publicado: (2021)

Epigenetic changes in the estrogen receptor α gene promoter: implications in sociosexual behaviors
por: Matsuda, Ken Ichi
Publicado: (2014)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Epigenetic regulation of estrogen signaling in breast cancer
por: Hervouet, Eric, et al.
Publicado: (2013)

Screening of Estrogenic-Disrupting Compounds in Dairy Products Based on the Estrogen Receptor Cocktail
por: Li, Xiaoqi, et al.
Publicado: (2022)

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
por: Chiu, Jen-Hwey, et al.
Publicado: (2017)

Estrogen receptor α is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer
por: Wu, Jingxun, et al.
Publicado: (2020)

A novel oncogenic enhancer of estrogen receptor-positive breast cancer
por: Bao, Chunjie, et al.
Publicado: (2022)

Sulforaphane Epigenetically Regulates Innate Immune Responses of Porcine Monocyte-Derived Dendritic Cells Induced with Lipopolysaccharide
por: Qu, Xueqi, et al.
Publicado: (2015)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Differential Effect of Phosphorylation-Defective Survivin on Radiation Response in Estrogen Receptor-Positive and -Negative Breast Cancer
por: Debeb, Bisrat G., et al.
Publicado: (2015)

Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
por: Kong, Lili, et al.
Publicado: (2021)

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
por: Bostner, Josefine, et al.
Publicado: (2017)

Response of Estrogen-Receptor-Positive Metastatic Breast Cancer to Olaparib in Late-Line Therapy
por: Kumeta, Toko, et al.
Publicado: (2019)

Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes
por: Mamnoon, Babak, et al.
Publicado: (2021)

Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs
por: Cheng, Ran, et al.
Publicado: (2020)

Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data
por: Alakwaa, Fadhl M., et al.
Publicado: (2017)

Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
por: Shupnik, Margaret A
Publicado: (2007)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

Quantification of angiogenesis in estrogen receptor-positive and negative breast carcinoma
por: Parentes-Vieira, JB, et al.
Publicado: (2007)

Estrogen receptor positive breast cancers and their association with environmental factors
por: St-Hilaire, Sophie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2sac3sa7l5n7tiuehgvuc7kcje